News|Articles|October 5, 2026

Russian Lab Worker Dies in Suspected Pneumonic Plague Case

Irkutsk anti-plague institute death prompts quarantines and conflicting official accounts.

A 28-year-old laboratory technician at the Irkutsk Research Anti-Plague Institute in Shelekhov, Siberia, has died after developing severe pneumonia, with Russian media and regional officials pointing to a suspected pneumonic plague exposure. According to Rospotrebnadzor, the Russian federal agency overseeing infectious disease, the employee was diagnosed with pneumonia of unknown etiology, and no microorganisms linked to her professional duties were recovered from her samples.¹ The US State Department said on October 4 it is aware of a possible death from pneumonic plague in Russia.¹

Russia maintains 11 natural plague foci under continuous anti-plague surveillance, and national reporting has described epidemiological stability for human plague since 2017. A laboratory-acquired infection would therefore fall outside the country's natural focus transmission patterns. CDC notes human plague cases in the eastern United States similarly occur among travelers from the West or after laboratory exposure.²

The technician was hospitalized September 29 and died overnight between October 1 and October 2. Accounts of the exposure conflict. Regional outlets reported she broke a test tube containing live Yersinia pestis at the institute, while a competing account described admission with pneumonic plague after return from Thailand.³

Rospotrebnadzor has denied any accident involving pathogenic microorganisms occurred at the institute and said the sanitary and epidemiological situation in Irkutsk and Shelekhov remains stable.¹ Alexei Tsydenov, head of the neighboring republic of Buryatia, initially attributed the death to an unspecified form of plague before his statement was softened.³ Anna Popova, head of Rospotrebnadzor and Russia's chief sanitary officer, traveled from Moscow for an emergency containment meeting with Irkutsk Governor Igor Kobzev.

Independent regional outlet Liudi Baikala reported nearly 200 people were placed under observation at the Shelekhov hospital, with quarantine imposed in at least one maternity ward.¹ Izvestia put the figure at 197 people as of October 2.³ Contacts have shown no signs of illness and have tested negative, according to officials. A nearby aluminum plant instructed staff to wear masks as a precaution.¹

CDC Guidance on Pneumonic Plague

Pneumonic plague is the only form of Y pestis infection transmissible person to person, spreading through respiratory droplets. CDC describes fever, headache, weakness, and rapidly progressive pneumonia with dyspnea, chest pain, cough, and sometimes bloody or watery sputum.² Untreated pneumonic plague is almost uniformly fatal, and CDC instructs clinicians to begin therapy on clinical suspicion without waiting for confirmatory testing.⁴

Gentamicin and fluoroquinolones are first-line agents in the United States, with treatment running 10 to 14 days and extended for patients with persistent fever.⁴ CDC lists ciprofloxacin 400 mg IV every 8 hours, levofloxacin 750 mg every 24 hours, moxifloxacin 400 mg every 24 hours, and gentamicin 5 mg/kg every 24 hours as adult first-line options for pneumonic or septicemic disease.⁴

Postexposure prophylaxis is indicated for close, sustained contact within 6 feet of a patient with pneumonic plague or direct contact with infected fluids or tissues, given as a single agent for 7 days.⁴ Preexposure prophylaxis is not considered necessary for responders and clinicians as long as standard and droplet precautions hold.⁴ CDC reports an average of seven human plague cases annually in the United States, with more than 80% presenting as bubonic disease.²

"We are monitoring the situation closely with the CDC and our other interagency partners," a State Department spokesperson said, adding officials encourage Russian authorities to share accurate information quickly.¹

Contagion has covered several recent domestic plague cases, including a confirmed human case in Pueblo County, Colorado, in July 2024, a cat-to-human bubonic transmission in Oregon in February 2024, and a fatal bubonic case in a New Mexico man reported in March 2024.

REFERENCES:
  1. Lister T, Vlasova S. Researcher at Russian plague laboratory dies of "unknown" infection. CNN. October 4, 2026.Accessed October 5, 2026.
  2. Centers for Disease Control and Prevention. Plague: maps and statistics. Updated March 25, 2025. Accessed October 5, 2026. https://www.cdc.gov/plague/maps-statistics/index.html
  3. Hospitals in Irkutsk impose quarantines after an employee at an anti-plague institute dies. Meduza. October 5, 2026.
  4. Centers for Disease Control and Prevention. Clinical care of plague. Updated May 15, 2024. Accessed October 5, 2026. https://www.cdc.gov/plague/hcp/clinical-care/index.html
  5. Centers for Disease Control and Prevention. Preventing plague. Updated March 5, 2025. Accessed October 5, 2026. https://www.cdc.gov/plague/prevention/index.html

Related to this article

FAQ: Pneumonic Plague
A laboratory technician at a Siberian anti-plague institute has died of pneumonia of unknown cause, prompting quarantines and contact monitoring while Russian officials stop short of confirming plague.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Measles Update: October 2, 2026
The latest CDC numbers show a 6.2% increase of measles cases from week-to-week. Last week there was a 5.4% increase in cases showing a continuing steady increase dictated by ongoing outbreaks across the US.